Cardiac dysfunction and N-terminal pro-B-type natriuretic peptide in exacerbations of chronic obstructive pulmonary disease

Internal Medicine Journal

Volumn 43, Issue 5, 2013, Pages 595-598

  Lee, M H S ^a   Chang, C L ^a   Davies, A R ^a   Davis, M ^a   Hancox, R J ^a,b  

^a WAIKATO HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BNP; COPD; Echocardiography; Heart failure; NT proBNP; TAPSE

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERINFLATION; LUNG PRESSURE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VENTRICULAR DYSFUNCTION;

EID: 84877882014     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12112     Document Type: Article

References (13)

1. Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD etal. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011; 66: 764-768.
2. Marcun R, Sustic A, Brguljan PM, Kadivec S, Farkas J, Kosnik M etal. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol 2012; 161: 156-159.
3. Medina AM, Marteles MS, Sáiz EB, Martínez SS, Laiglesia FR, Rodríguez JAN etal. Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases. Eur J Intern Med 2011; 22: 167-171.
4. Prahash A, Lynch T. B-type natriuretic peptide: a diagnostic, prognostic, and therapeutic tool in heart failure. Am J Crit Care 2004; 13: 46-53.
5. Inoue Y, Kawayama T, Iwanaga T, Aizawa H. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern Med. 2009; 48: 503-512.
6. Funk G-C, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 2008; 133: 1354-1359.
7. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D etal. Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39: 51-58.
8. Gale CP, White JES, Hunter A, Owen J, Allen J, Watson J etal. Predicting mortality and hospital admission in patients with COPD: significance of NT pro-BNP, clinical and echocardiographic assessment. J Cardiovasc Med (Hagerstown) 2011; 12: 613-618.
9. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA etal. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
10. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K etal. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
11. Alpert JS. The effect of right ventricular dysfunction on left ventricular form and function. Chest 2001; 119: 1632-1633.
12. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest 1996; 109: 1446-1451.
13. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA etal. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362: 217-227.